Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Respir Res
; 15: 148, 2014 Nov 25.
Article
in En
| MEDLINE
| ID: mdl-25420924
Full text:
1
Database:
MEDLINE
Main subject:
Pulmonary Artery
/
Monocrotaline
/
Glycyrrhizic Acid
/
HMGB1 Protein
/
Arterial Pressure
/
Vascular Remodeling
/
Hypertension, Pulmonary
/
Antihypertensive Agents
Type of study:
Prognostic_studies
Language:
En
Journal:
Respir Res
Year:
2014
Type:
Article